Lido Advisors
WST icon

Lido Advisors’s West Pharmaceutical WST Stock Holding History

Lido Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73M Buy
4,827
+733
+18% +$224K ﹤0.01% 860
2026
Q1 		$1.03M Buy
4,094
+2,671
+188% +$665K ﹤0.01% 953
2025
Q4 		$378K Buy
1,423
+26
+2% +$7.11K ﹤0.01% 1446
2025
Q3 		$367K Buy
1,397
+85
+6% +$20.7K ﹤0.01% 1389
2025
Q2 		$287K Sell
1,312
-1,532
-54% -$327K ﹤0.01% 1365
2025
Q1 		$637K Buy
2,844
+87
+3% +$24K ﹤0.01% 940
2024
Q4 		$903K Sell
2,757
-38
-1% -$12K ﹤0.01% 798
2024
Q3 		$839K Buy
2,795
+1,803
+182% +$552K ﹤0.01% 785
2024
Q2 		$327K Sell
992
-8
-0.8% -$2.83K ﹤0.01% 1078
2024
Q1 		$396K Buy
1,000
+40
+4% +$14.8K ﹤0.01% 971
2023
Q4 		$338K Buy
960
+172
+22% +$60.9K ﹤0.01% 985
2023
Q3 		$296K Buy
788
+106
+16% +$41K ﹤0.01% 921
2023
Q2 		$261K Buy
+682
New +$244K ﹤0.01% 1003
2022
Q4 		– Sell
-1,059
Closed -$260K – 1091
2022
Q3 		$260K Sell
1,059
-1,526
-59% -$465K ﹤0.01% 811
2022
Q2 		$781K Buy
2,585
+13
+0.5% +$4.23K 0.01% 407
2022
Q1 		$1.06M Buy
2,572
+62
+2% +$24.3K 0.01% 385
2021
Q4 		$1.18M Buy
2,510
+409
+19% +$176K 0.01% 388
2021
Q3 		$891K Sell
2,101
-159
-7% -$67K 0.01% 436
2021
Q2 		$812K Sell
2,260
-76
-3% -$25.1K 0.01% 425
2021
Q1 		$658K Buy
2,336
+17
+0.7% +$4.87K 0.01% 429
2020
Q4 		$656K Sell
2,319
-474
-17% -$133K 0.01% 413
2020
Q3 		$768K Buy
2,793
+1,421
+104% +$376K 0.02% 310
2020
Q2 		$312K Sell
1,372
-152
-10% -$29.9K 0.01% 438
2020
Q1 		$232K Buy
1,524
+91
+6% +$14K 0.01% 481
2019
Q4 		$215K Buy
+1,433
New +$209K 0.01% 607

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Lido Advisors's WST Position: Q2 2026 in Review

Lido Advisors increased its West Pharmaceutical (WST) stake by 18% in Q2 2026, buying an estimated $224K and bringing the position to 4,827 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #860.

Lido Advisors first reported a position in WST in Q4 2019 and has held it in 25 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Lido Advisors held 4,827 shares of West Pharmaceutical worth $1.73M as of Q2 2026.
  • Lido Advisors bought 733 West Pharmaceutical shares in Q2 2026, an estimated $224K.
  • West Pharmaceutical made up ﹤0.01% of Lido Advisors's portfolio in Q2 2026, its #860 holding.
  • Lido Advisors first reported a position in West Pharmaceutical in Q4 2019 and has held it in 25 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.